Suraksha Diagnostic Made Cautious Start , Shares Open at ₹438, 1% Below Issue Price!Suraksha Diagnostic Made Cautious Start , Shares Open at ₹438, 1% Below Issue Price!

Suraksha Diagnostic shares have a modest market debut, opening at ₹438 on the NSE, reflecting a nearly 1% discount from its issue price. The stock shows a cautious start in the market, indicating mixed investor sentiment on Day 1.

Suraksha Diagnostic Limited IPO achieved a 1.27x subscription on Day 3, with notable interest from institutional investors. QIBs subscribed at 1.74x, while NIIs stood at 1.41x. Retail investors (RIIs) showed a more cautious response, subscribing at 0.95x, reflecting a mixed yet positive market sentiment.

Read More: Smallcap stock jumps after it monetizes 11 acres of land in Hyderabad for ₹142 Cr

Suraksha Diagnostic Limited offers comprehensive pathology, radiology, and consultation services across West Bengal, Bihar, Assam, and Meghalaya. With a network of 13 hub centers, 36 spoke centers, and 166 sample collection points, the company provides 2,300+ diagnostic tests, vaccinations, and customized packages, using a hub-and-spoke model to enhance efficiency and accessibility.

Read More: Transformer stock jumps after company to acquire controlling stake in Posco Poggenamp Electrical Steel

The main objective of Suraksha Diagnostic Limited is to enhance visibility and brand image and create a public market through equity listing. 

Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time The securities quoted are exemplary and are not recommendatory.